sample of austria report

8/3/2019 Sample of Austria Report

1/6

in

LIFE

Sc enceSAUSTRIA

Al

lAbout

WhenWhat

Who

WhereHow

THE

REPORT

COMPLETE

ATHARVALIFESCIENCES

CONSULTING

ATHARVA LIFESCIENCES CONSULTING PVT. LTD.


2/6

Atharva LifeSciences Consulting Pvt. Ltd. 2

foreword

Austria has a long history of lifesciences.

The interest in science can somewhat be judged by the face

that the Vienna Polytechnic Institute was set up in 1815, and

biotechnology was taught from the beginning.

Biotechnology, human medicine and medical

engineering are not only growth sectors in Eu-

rope, but are particularly booming in Austria.

Far more than one hundred companies are-

carrying out research and development work

in biotechnology. Moreover, Austria is at the

cutting edge of cancer research.

Interested in Austria as an investment desti-

nation? Heres another Atharva GloLife report

to make it easier for you!

Happy Investing!

Karnvir Singh Mundrey

Editor

Director

Atharva Lifesciences Consulting Pvt. Ltd.


3/6


1. INTRODUCTION ................................................................................. 6

1.1. History of Lifesciences in Austria......................................................... 7

2. LIFESCIENCES IN AUSTRIA- AN OVERVIEW .................................. 9

2.1. Biotechnology, Human Medicine and Medical ....................................

Engineering- The Leading Sectors in Austria ...................................... 10

2.2. List of Major Lifescience Events in Austria .......................................... 13

2.3. List of Major Lifescience Associations and Societies in Austria ........... 14

2.4. List of Biotech Clusters in Austria ........................................................ 16

3. INVESTMENT FACTORS ................................................................... 18

4. DOING BUSINESS IN AUSTRIA......................................................... 20

4.1. Types of Business ............................................................................... 20

4.2. Visa Requirements .............................................................................. 28

4.3. Establishing a Company ...................................................................... 30

4.4. Registering the Business ..................................................................... 31

4.5. Transferring Assets .............................................................................. 32

4.6. Business Premises .............................................................................. 33

4.7. Financing a Business .......................................................................... 34

4.8. Incentive Programs .............................................................................. 38

4.9. Employee and Social Security ............................................................. 40

5. THE TAX SYSTEM .............................................................................. 41

6. THE LEGAL FRAMEWORK ................................................................ 46

7. OPPORTUNITIES AND REQUIREMENTS ......................................... 52

8. PROFILES OF MAJOR LIFESCIENCES FIRMS ................................ 53

Table of Contents


4/6


Life sciences, pharmaceuticals and

biotechnology are among the most

important technological and economic

areas of the 21st century. Austria offers

networks of well-established pharmaceutical

companies, innovative biotechnology rms,leading research institutes and important

centres of expertise, providing the ideal

backdrop for a life science location of

international importance.

Life sciences are considered one of the most

promising sectors of the Austrian economy.

Austrian biotech rms are predominantly

companies with a pure research focus,

over half of which are involved in the health

sector. The most important location for lifesciences is Vienna and the surrounding

area, as it provides the ideal conditions for

this dynamic, knowledge-intensive industry.

Austria is a pioneer in cancer research.

Nationwide COMET funding program has

set up Oncotyrol, the rst K1 Center of

Excellence which will devote its efforts

over the next four years to the research

and development of excellent quality

technologies to ght cancer. It aims todevelop individual, tailor-made therapeutic

and medical treatment concepts. Moreover,

several companies belonging to the Life

Science Cluster Austria Vienna Region

(LISA VR) have come up with very promising

approaches in the search for anti-cancer

drugs.

Austrian biotech rms are among the best

in the world when it comes to developing

vaccines and new active ingredients to ght

life-threatening illnesses. A high percentage

of companies work in research and stand

at 21% research rate of the Austrian

biotechnology industry.

Many of the SMEs were founded by one

of 15 Austrian universities which are active

in the eld of biotechnology. Major biotechcompanies in Austria include Baxter, Amgen

and Novartis.

Evidence that Austrian companies are

truly world class can be seen in the

example of the Viennese biotechnology

start-up Apeiron. In 2010 they concluded

a far-reaching cooperation agreement with

the international pharmaceutical giant,

GlaxoSmithKline that covers the licensing

of new therapeutic agents, including one totreat acute respiratory distress syndrome

(ARDS).

2. LIFESCIENCES IN

AUSTRIA-AN OVERVIEW


5/6


Biotechnology, human medicine and medical engineering are not only growth sectors but

are particularly booming in Austria. More than one hundred companies are carrying out

research and development work in biotechnology.

Biotechnology is the integrated application of natural sciences and engineering with the

specic aim of using organisms and/or parts for the creation of products, or for their use in

different processes. Biotechnology is divided in different branches according to the different

elds of application, namely: Red Biotechnology, Green Biotechnology, Grey Biotechnology,

White Biotechnology and Blue Biotechnology.

2.1. Biotechnology, Human Medicineand Medical Engineering-

The Leading Sectors in Austria

Bio

Technology

Austriain

Green

BiotechnologyWhite

Biotechnology

Gray

Biotechnology

Blue

BiotechnologyRed

Biotechnology


6/6


APEPTICO Forschung Und Entwick-

lung

APEPTICO is a clinical stage bio-

tech company in Vienna, Austria.The company develops new peptide-

based medicinal drugs for the clinical

treatment of severe and chronic dis-

eases.

Their peptide molecules correspond

to validated, pharmacodynamic ac-

tive structures and domains of well-

known proteins and biopharmaceuti-cals.

All the products address highly prof-

itable and growing markets. They

collect molecular, structural, biologi-

cal & medical data of well-charac-

terised proteins and biopharmaceu-

ticals in our proprietary data base

PEPBASE(TM).

Identication of a bio-active moiety

is the rst step of PEPSCREEN(TM),

our fast-track product devel-

opment pathway. The applica-

tions PEPSCREEN(TM) and

PEPBASE(TM) in combination with

our cumulated Research & Develop-

ment experience enables to create

novel compounds which allow for in-

tellectual property protection, and fa-

cilitates lower clinical failure rates, at

reduced costs and decreased busi-

ness risks.

APEPTICOs lead molecules of the

AP301 family are synthetic peptides.

AP301 is water soluble and can be

administered into the lung by instilla-

tion or by oral inhalation.

Formulated AP301 can be nebulised

and the resulting aerosol is com-posed of peptide/water droplets of

8. PROFILES OF MAJOR

LIFESCIENCES FIRMS

sample of austria report

Documents